Resound Nexia vs Sontro Soundwave

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earned a SoundScore of 4.0/5 and an A grade, ranking #28 of 39 prescription hearing aids tested. The Nexia demonstrates clear strengths in specific areas. Feedback handling is excellent at 5.0/5, scoring 0.28 points above the category average—users can expect stable performance without whistling during typical daily activities. Own-voice comfort also stands out at 3.6/5, a solid score that sits 0.90 points above average, suggesting wearers may find their own voice sounds more natural compared to many competitors. However, speech performance presents a more mixed picture. Speech in quiet measures 3.2/5—solid in absolute terms but 0.19 points below the category average. More notably, speech in noise scores just 1.0/5, falling 1.11 points below average. This represents a significant limitation for users who frequently encounter challenging listening environments like restaurants or group conversations. Music streaming scores 2.8/5, essentially matching the category average. At this price point, several alternatives deliver stronger overall performance. The Phonak Sphere Infinio, Oticon Intent, and Oticon Real all score notably higher while occupying the same premium tier. Budget-conscious buyers might also consider options like the Jabra Enhance Select 500 at a lower price point with competitive sound quality. The Nexia may be best suited for users who prioritize feedback stability and own-voice comfort over speech-in-noise performance.

The Sontro Soundwave is a mid-priced OTC hearing aid that earns a B grade with a SoundScore of 3.0/5 in our lab testing. At $849, this behind-the-ear device uses disposable batteries and sits in the lower tier of OTC performance, ranking #61 of 65 devices in its category. The Soundwave's strongest attribute is own-voice comfort, scoring 3.6/5—a solid result that sits 1.09 points above the OTC category average. This makes it relatively comfortable for wearers who are sensitive to hearing their own voice sound unnatural or boomy. However, other performance areas present significant limitations. Speech clarity scores are below average in both quiet and noisy environments. Speech in quiet scores 2.7/5 (0.12 points below average), while speech in noise drops to 1.2/5 (0.28 points below average). Feedback handling is a notable weakness at 2.5/5, falling 2.04 points below the category average of 4.54/5. Perhaps most limiting is the music streaming score of 0.0/5, indicating this device does not support phone audio streaming—a feature many competitors in this price range offer. Consumers prioritizing own-voice comfort on a moderate budget may find the Soundwave acceptable, but those seeking strong speech clarity or streaming capability should consider alternatives. Several higher-performing OTC devices are available at similar or lower price points, including options like the Lexie Lumen or HearingAssist Control that deliver comparable or better overall sound quality.